The glycoprotein clusterin (CLU) is involved in cell proliferation and DNA damage repair and is highly expressed in tumor cells. Here, we aimed to investigate the effects of CLU dysregulation on two human astrocytic cell lines: CCF-STTG1 astrocytoma cells and SV-40 immortalized normal human astrocytes. We observed that suppression of CLU expression by RNA interference inhibited cell proliferation, triggered the DNA damage response, and resulted in cellular senescence in both cell types tested. To further investigate the underlying mechanism behind these changes, we measured reactive oxygen species, assessed mitochondrial function, and determined selected markers of the senescence-associated secretory phenotype. Our results suggest that CLU deficiency triggers oxidative stress-mediated cellular senescence associated with pronounced alterations in mitochondrial membrane potential, mitochondrial mass, and expression levels of OXPHOS complex I, II, III and IV, indicating mitochondrial dysfunction. This report shows the important role of CLU in cell cycle maintenance in astrocytes. Based on these data, targeting CLU may serve as a potential therapeutic approach valuable for treating gliomas.

Department of Physiology Faculty of Science Charles University Prague 128 00 Czech Republic

Laboratory of Genome Integrity Institute of Molecular Genetics of the Czech Academy of Sciences Prague 142 20 Czech Republic

Zobrazit více v PubMed

Cohen J, Torres C (2019) Astrocyte senescence: evidence and significance. Aging Cell 18(3):e12937. 10.1111/acel.12937 PubMed PMC

Herranz N, Gil J (2016) Mitochondria and senescence: new actors for an old play. EMBO J 35(7):701–702. 10.15252/embj.201694025 PubMed PMC

Herbig U, Jobling WA, Chen BP, Chen DJ, Sedivy JM (2004) Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell 14(4):501–513. 10.1016/s1097-2765(04)00256-4 PubMed

Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88(5):593–602. 10.1016/s0092-8674(00)81902-9 PubMed

Childs BG, Baker DJ, Kirkland JL, Campisi J, van Deursen JM (2014) Senescence and apoptosis: dueling or complementary cell fates? EMBO Rep 15(11):1139–1153. 10.15252/embr.201439245 PubMed PMC

Beausejour CM, Krtolica A, Galimi F, Narita M, Lowe SW, Yaswen P, Campisi J (2003) Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J 22(16):4212–4222 PubMed PMC

Deb M, Sengupta D, Rath SK, Kar S, Parbin S, Shilpi A, Pradhan N, Bhutia SK et al (2015) Clusterin gene is predominantly regulated by histone modifications in human colon cancer and ectopic expression of the nuclear isoform induces cell death. Biochim Biophys Acta 1852(8):1630–1645. 10.1016/j.bbadis.2015.04.021 PubMed

Morgan TE, Laping NJ, Rozovsky I, Oda T, Hogan TH, Finch CE, Pasinetti GM (1995) Clusterin expression by astrocytes is influenced by transforming growth factor beta 1 and heterotypic cell interactions. J Neuroimmunol 58(1):101–110. 10.1016/0165-5728(94)00194-s PubMed

Trougakos IP, Gonos ES (2002) Clusterin/apolipoprotein J in human aging and cancer. Int J Biochem Cell Biol 34(11):1430–1448 PubMed

Pasinetti GM, Johnson SA, Oda T, Rozovsky I, Finch CE (1994) Clusterin (SGP-2): a multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain. J Comp Neurol 339(3):387–400. 10.1002/cne.903390307 PubMed

Yao M, Fang M, Zheng W, Dong Z, Yao D (2018) Role of secretory clusterin in hepatocarcinogenesis. Transl Gastroenterol Hepatol 3:48. 10.21037/tgh.2018.07.13 PubMed PMC

Pucci S, Bonanno E, Pichiorri F, Angeloni C, Spagnoli LG (2004) Modulation of different clusterin isoforms in human colon tumorigenesis. Oncogene 23(13):2298–2304. 10.1038/sj.onc.1207404 PubMed

Wang X, Xie J, Lu X, Li H, Wen C, Huo Z, Xie J, Shi M et al (2017) Melittin inhibits tumor growth and decreases resistance to gemcitabine by downregulating cholesterol pathway gene CLU in pancreatic ductal adenocarcinoma. Cancer Lett 399:1–9. 10.1016/j.canlet.2017.04.012 PubMed

Arumugam P, Samson A, Ki J, Song JM (2017) Knockdown of clusterin alters mitochondrial dynamics, facilitates necrosis in camptothecin-induced cancer stem cells. Cell Biol Toxicol 33(3):307–321. 10.1007/s10565-016-9378-1 PubMed

Chun YJ (2014) Knockdown of clusterin expression increases the in vitro sensitivity of human prostate cancer cells to paclitaxel. J Toxicol Environ Health A 77(22–24):1443–1450. 10.1080/15287394.2014.951760 PubMed

Chi KN, Zoubeidi A, Gleave ME (2008) Custirsen (OGX-011): a second-generation antisense inhibitor of clusterin for the treatment of cancer. Expert Opin Investig Drugs 17(12):1955–1962. 10.1517/13543780802528609 PubMed

Shi H, Deng JH, Wang Z, Cao KY, Zhou L, Wan H (2013) Knockdown of clusterin inhibits the growth and migration of renal carcinoma cells and leads to differential gene expression. Mol Med Rep 8(1):35–40. 10.3892/mmr.2013.1470 PubMed

So A, Sinnemann S, Huntsman D, Fazli L, Gleave M (2005) Knockdown of the cytoprotective chaperone, clusterin, chemosensitizes human breast cancer cells both in vitro and in vivo. Mol Cancer Ther 4(12):1837–1849. 10.1158/1535-7163.Mct-05-0178 PubMed

Tan J, Guo W, Yang S, Han D, Li H (2021) The multiple roles and therapeutic potential of clusterin in non-small-cell lung cancer: a narrative review. Transl Lung Cancer Res 10(6):2683–2697. 10.21037/tlcr-20-1298 PubMed PMC

Huang H, Wang L, Li M, Wang X, Zhang L (2014) Secreted clusterin (sCLU) regulates cell proliferation and chemosensitivity to cisplatin by modulating ERK1/2 signals in human osteosarcoma cells. World J Surg Oncol 12:255. 10.1186/1477-7819-12-255 PubMed PMC

Mitsufuji S, Iwagami Y, Kobayashi S, Sasaki K, Yamada D, Tomimaru Y, Akita H, Asaoka T et al (2022) Inhibition of clusterin represses proliferation by inducing cellular senescence in pancreatic cancer. Ann Surg Oncol 29(8):4937–4946. 10.1245/s10434-022-11668-0 PubMed

Bhat R, Crowe EP, Bitto A, Moh M, Katsetos CD, Garcia FU, Johnson FB, Trojanowski JQ et al (2012) Astrocyte senescence as a component of Alzheimer’s disease. PLoS One 7(9):e45069. 10.1371/journal.pone.0045069 PubMed PMC

Bitto A, Sell C, Crowe E, Lorenzini A, Malaguti M, Hrelia S, Torres C (2010) Stress-induced senescence in human and rodent astrocytes. Exp Cell Res 316(17):2961–2968. 10.1016/j.yexcr.2010.06.021 PubMed

Jiang J, Jiang J, Zuo Y, Gu Z (2013) Rapamycin protects the mitochondria against oxidative stress and apoptosis in a rat model of Parkinson’s disease. Int J Mol Med 31(4):825–832. 10.3892/ijmm.2013.1280 PubMed

Davalli P, Mitic T, Caporali A, Lauriola A, D’Arca D (2016) ROS, cell senescence, and novel molecular mechanisms in aging and age-related diseases. Oxid Med Cell Longev 2016:3565127. 10.1155/2016/3565127 PubMed PMC

Wiggins AK, Shen PJ, Gundlach AL (2003) Delayed, but prolonged increases in astrocytic clusterin (ApoJ) mRNA expression following acute cortical spreading depression in the rat: evidence for a role of clusterin in ischemic tolerance. Brain Res Mol Brain Res 114(1):20–30. 10.1016/s0169-328x(03)00124-4 PubMed

Feoktistova M, Geserick P, Leverkus M (2016) Crystal violet assay for determining viability of cultured cells. Cold Spring Harb Protoc 2016(4):pdb.prot087379. 10.1101/pdb.prot087379 PubMed

Honc O, Novotny J (2023) Methadone potentiates the cytotoxicity of temozolomide by impairing calcium homeostasis and dysregulation of PARP in glioblastoma cells. Cancers (Basel) 15(14). 10.3390/cancers15143567 PubMed PMC

Chen F, Swartzlander DB, Ghosh A, Fryer JD, Wang B, Zheng H (2021) Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer’s disease neuropathology. Mol Neurodegener 16(1):5. 10.1186/s13024-021-00426-7 PubMed PMC

Kularatne RN, Bulumulla C, Catchpole T, Takacs A, Christie A, Stefan MC, Csaky KG (2020) Protection of human retinal pigment epithelial cells from oxidative damage using cysteine prodrugs. Free Radic Biol Med 152:386–394. 10.1016/j.freeradbiomed.2020.03.024 PubMed

Lee HC, Yin PH, Chi CW, Wei YH (2002) Increase in mitochondrial mass in human fibroblasts under oxidative stress and during replicative cell senescence. J Biomed Sci 9(6 Pt 1):517–526. 10.1007/bf02254978 PubMed

Park YY, Lee S, Karbowski M, Neutzner A, Youle RJ, Cho H (2010) Loss of MARCH5 mitochondrial E3 ubiquitin ligase induces cellular senescence through dynamin-related protein 1 and mitofusin 1. J Cell Sci 123(Pt 4):619–626. 10.1242/jcs.061481 PubMed PMC

Foster EM, Dangla-Valls A, Lovestone S, Ribe EM, Buckley NJ (2019) Clusterin in Alzheimer’s disease: mechanisms, genetics, and lessons from other pathologies. Front Neurosci 13:164. 10.3389/fnins.2019.00164 PubMed PMC

Kang B-H, Shim Y-J, Tae Y-K, Song J-A, Choi B-K, Park I-S, Min B-H (2014) Clusterin stimulates the chemotactic migration of macrophages through a pertussis toxin sensitive G-protein-coupled receptor and Gβγ-dependent pathways. Biochem Biophys Res Commun 445(3):645–650. 10.1016/j.bbrc.2014.02.071 PubMed

Kumari R, Jat P (2021) Mechanisms of cellular senescence: cell cycle arrest and senescence associated secretory phenotype. Front Cell Dev Biol 9:645593. 10.3389/fcell.2021.645593 PubMed PMC

He G, Siddik ZH, Huang Z, Wang R, Koomen J, Kobayashi R, Khokhar AR, Kuang J (2005) Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities. Oncogene 24(18):2929–2943. 10.1038/sj.onc.1208474 PubMed

Lawless C, Jurk D, Gillespie CS, Shanley D, Saretzki G, von Zglinicki T, Passos JF (2012) A stochastic step model of replicative senescence explains ROS production rate in ageing cell populations. PLoS One 7(2):e32117. 10.1371/journal.pone.0032117 PubMed PMC

Freund A, Patil CK, Campisi J (2011) p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J 30(8):1536–1548. 10.1038/emboj.2011.69 PubMed PMC

Passos JF, Nelson G, Wang C, Richter T, Simillion C, Proctor CJ, Miwa S, Olijslagers S et al (2010) Feedback between p21 and reactive oxygen production is necessary for cell senescence. Mol Syst Biol 6:347. 10.1038/msb.2010.5 PubMed PMC

Villeneuve C, Guilbeau-Frugier C, Sicard P, Lairez O, Ordener C, Duparc T, De Paulis D, Couderc B et al (2013) p53-PGC-1α pathway mediates oxidative mitochondrial damage and cardiomyocyte necrosis induced by monoamine oxidase-A upregulation: role in chronic left ventricular dysfunction in mice. Antioxid Redox Signal 18(1):5–18. 10.1089/ars.2011.4373 PubMed PMC

Lee S, Jeong SY, Lim WC, Kim S, Park YY, Sun X, Youle RJ, Cho H (2007) Mitochondrial fission and fusion mediators, hFis1 and OPA1, modulate cellular senescence. J Biol Chem 282(31):22977–22983. 10.1074/jbc.M700679200 PubMed

Sagiv A, Krizhanovsky V (2013) Immunosurveillance of senescent cells: the bright side of the senescence program. Biogerontology 14(6):617–628. 10.1007/s10522-013-9473-0 PubMed

Rodier F, Muñoz DP, Teachenor R, Chu V, Le O, Bhaumik D, Coppé JP, Campeau E et al (2011) DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion. J Cell Sci 124(Pt 1):68–81. 10.1242/jcs.071340 PubMed PMC

Hou J, Kim S, Sung C, Choi C (2017) Ginsenoside Rg3 prevents oxidative stress-induced astrocytic senescence and ameliorates senescence paracrine effects on glioblastoma. Molecules 22(9). 10.3390/molecules22091516 PubMed PMC

Benzing WC, Wujek JR, Ward EK, Shaffer D, Ashe KH, Younkin SG, Brunden KR (1999) Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice. Neurobiol Aging 20(6):581–589. 10.1016/s0197-4580(99)00065-2 PubMed

Sultana P, Novotny J (2024) Clusterin: a double-edged sword in cancer and neurological disorders. EXCLI J 23:912–936. 10.17179/excli2024-7369 PubMed PMC

Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297(5580):353–356. 10.1126/science.1072994 PubMed

Trougakos IP, So A, Jansen B, Gleave ME, Gonos ES (2004) Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress. Cancer Res 64(5):1834–1842. 10.1158/0008-5472.can-03-2664 PubMed

Scaltriti M, Bettuzzi S, Sharrard RM, Caporali A, Caccamo AE, Maitland NJ (2004) Clusterin overexpression in both malignant and nonmalignant prostate epithelial cells induces cell cycle arrest and apoptosis. Br J Cancer 91(10):1842–1850. 10.1038/sj.bjc.6602193 PubMed PMC

Serrano A, Redondo M, Tellez T, Castro-Vega I, Roldan MJ, Mendez R, Rueda A, Jimenez E (2009) Regulation of clusterin expression in human cancer via DNA methylation. Tumour Biol 30(5–6):286–291. 10.1159/000259912 PubMed

Heroux MS, Chesnik MA, Halligan BD, Al-Gizawiy M, Connelly JM, Mueller WM, Rand SD, Cochran EJ et al (2014) Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomics. Physiol Genomics 46(13):467–481. 10.1152/physiolgenomics.00034.2014 PubMed PMC